Table 1.
Overall (n = 410) | Unvaccinated (n = 201) | Vaccinated (n = 209) | p | |
---|---|---|---|---|
Mean age in years (SD; range) | 70.7 (13.9; 28–100) | 65.6 (14.3) | 75.6 (11.6) | <0.001 |
Age by groups | ||||
Under 65 | 132 (32.2%) | 103 (51.2%) | 29 (13.9%) | <0.001 |
Between 65 and 75 years | 103 (25.1%) | 45 (22.4%) | 58 (27.8%) | |
Between 75 and 85 years | 113 (27.6%) | 30 (14.9%) | 83 (39.7%) | |
More than 85 years | 62 (15.1%) | 23 (11.4%) | 39 (18.7%) | |
Sex | ||||
Male | 202 (49.3%) | 101 (50.2%) | 101 (48.3%) | 0.697 |
Female | 208 (50.7%) | 100 (49.8%) | 108 (51.7%) | |
Barthel | ||||
> 60 | 319 (77.8%) | 167 (89.8%) | 152 (79.2%) | 0.004 |
≤ 60 | 59 (14.4%) | 19 (10.2%) | 40 (20.8%) | |
Not available | 32 (7.8%) | – | – | |
Charlson | ||||
<3 | 232 (78.8%) | 176 (87.6%) | 147 (70.3%) | <0.001 |
≥ | 87 (21.2%) | 25 (12.4%) | 62 (29.7%) | |
Comorbidities | ||||
Obesity | 88 (21.5%) | 40 (19.9%) | 48 (23%) | 0.450 |
Chronic Respiratory Disease | 145 (35.4%) | 49 (24.4%) | 96 (45.9%) | <0.001 |
Ischemic heart disease / Heart failure | 50 (12.2%) | 14 (7%) | 36 (17.2%) | 0.002 |
Renal failure | 49 (12%) | 20 (10%) | 29 (13.9%) | 0.221 |
Chronic liver disease | 7 (1.7%) | 4 (2%) | 3 (1.4%) | 0.719 |
Hematologic malignancy | 9 (2.2%) | 4 (2%) | 5 (2.4%) | 0.999 |
Other neoplasms | 60 (7.3%) | 12 (6%) | 18 (8.6%) | 0.304 |
Diabetes | 109 (26.6%) | 37 (18.4%) | 72 (34.4%) | <0.001 |
HBP | 256 (62.4%) | 106 (52.7%) | 150 (71.8%) | <0.001 |
Cognitive impairment | 49 (12%) | 16 (8%) | 33 (15.8%) | 0.015 |
Other neurological diseases | 96 (23.4%) | 41 (20.4%) | 55 (26.3%) | 0.157 |
Depressive syndrome | 61 (14.9%) | 27 (13.4%) | 34 (16.3%) | 0.420 |
Heart failure on admission | 20 (4.9%) | 6 (3%) | 14 (6.7%) | 0.081 |
Cardiovascular event during admission | 6 (1.5%) | Twenty-one% | 4 (1.9%) | 0.686 |
Immunosuppressive treatment | 14 (3.4%) | 6 (3%) | 8 (3.8%) | 0.639 |
Institutionalized | 32 (7.8%) | 10 (5%) | 22 (10.5%) | 0.036 |
ICU admission | 24 (5.9%) | 18 (9%) | 6 (2.9%) | 0.009 |
In-hospital death | 142 (34.6%) | 49 (24.4%) | 93 (44.5%) | <0.001 |